Back to FIRST TRUST ADVISORS LP FIRST TRUST ADVISORS LP

RXRXRXRX
Showing 7 of 15 quarters

Position history for FIRST TRUST ADVISORS LPFIRST TRUST ADVISORS LP's holdings in RECURSION PHARMACEUTICALS IN

Yes. First Trust holds 3,041,829 shares of RXRX (Recursion Pharmaceuticals in), worth $11.2M, as of its Q2 2026 13F filing. It increased the position by 431,103 shares (+16.5%) from Q1 2026. First Trust has held RXRX since Q1 2025, across 6 quarterly 13F filings.

Current Value

$11.2M

Current Shares

3M

Total Value Change

+$11.2M

Total Shares Change

+3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
3M
+16.5%
$11.2M0.0%$3.67
32
2026-Q1
Increased
2.6M
+15.2%
$8M0.0%$3.54
32
2025-Q4
Increased
2.3M
+26.1%
$9.3M0.0%$4.11
34
2025-Q3
Decreased
1.8M
-4.4%
$8.8M0.0%$4.91
0
2025-Q2
Increased
1.9M
+82.3%
$9.5M0.0%$5.03
43
2025-Q1
New
1M
-
$5.5M0.0%$5.81
37
2024-Q3
Exited
0
-100.0%
$00.0%$6.98
0

Other major holders of RXRX: BAILLIE GIFFORD & CO, ARK Investment Management LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used